医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

His-Purkinje conduction system pacing combined with atriove-ntricular node ablation improves quality of life in older patients with persistent atrial fibrillation refractory to multiple ablation procedures

摘要BACKGROUND Recurrence of atrial fibrillation (AF) is common in patients with persistent AF even after multiple ablation pro-cedures. His-Purkinje conduction system pacing (HPCSP) combined with atrioventricular node ablation (AVNA) is effective in ma-naging patients with AF and heart failure. This study aimed to determine whether HPCSP combined with AVNA can improve qua-lity of life and alleviate symptoms in older patients with symptomatic persistent AF refractory to multiple ablation procedures, as well as evaluate the feasibility and safety of this therapy. METHODS Older patients (≥ 65 years) with symptomatic persistent AF refractory to at least two ablation procedures were trea-ted with combined HPCSP and AVNA. The success rates and complications were recorded. Pacing parameters, European Heart Rh-ythm Association (EHRA) scores, and Atrial Fibrillation Effect on Quality-of-Life (AFEQT) scores obtained perioperatively were co-mpared with those recorded at the 6-month follow-up examination. RESULTS Thirty-one patients were enrolled; of those, only thirty patients were eventually treated with AVNA because one pa-tient developed a complete atrioventricular block following the withdrawal of the His bundle pacing lead. The success rates were 100% for HPCSP (22 cases with His bundle pacing, and 9 cases with left bundle branch pacing) and 93.3% (28/30) for AVNA, re-spectively. By the 6-month follow-up examination, EHRA scores improved significantly (3.00 ± 0.73 vs. 2.44 ± 0.63, P = 0.014) and AFEQT scores increased markedly (49.6 ± 20.6 vs. 70.9 ± 14.0, P = 0.001). No severe complications developed. CONCLUSIONS When used in older patients with symptomatic persistent AF refractory to multiple ablation procedures, HPC-SP combined with AVNA significantly alleviated symptoms and improved quality of life during short-term follow-up. This thera-py was proved to be safe and effective in this patient population.

更多
广告
作者 Peng QI [1] Yi-Zhen YANG [2] Liang SHI [2] Yan-Jiang WANG [2] Ying TIAN [2] Ke-Xin YUAN [3] Xue-Feng CHEN [3] Shu-Ren LI [3] Yi DANG [3] Xing-Peng LIU [2] 学术成果认领
作者单位 Heart Center,Beijing Chaoyang Hospital,Capital Medical University,Beijing,China;Heart Center,Hebei General Hospital,Hebei,China [1] Heart Center,Beijing Chaoyang Hospital,Capital Medical University,Beijing,China [2] Heart Center,Hebei General Hospital,Hebei,China [3]
栏目名称
发布时间 2023-03-16(万方平台首次上网日期,不代表论文的发表时间)
提交
  • 浏览8
  • 下载0
老年心脏病学杂志(英文版)

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷